Hadrup BioMed Holding ApS: Financial statements 2019
CVR: 38034871
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Hadrup BioMed Holding ApS (CVR 38034871) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 50,000 and a net result of DKK 50,000 compared with DKK 0 the year before. Equity in the 2019 report amounted to DKK 90,100. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 50,000
- Profit/Loss
- DKK 50,000
- Equity
- DKK 90,100
- Total Assets
- DKK 90,100
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Hadrup BioMed Holding ApS has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK 0.
About Hadrup BioMed Holding ApS
Hadrup BioMed Holding ApS is a Danish company of the type Anpartsselskab based in Virum, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Hadrup BioMed Holding IVS. The management consists of Sine Hadrup. The company is owned by Sine Hadrup. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -28,316 and a net result of DKK 7,013 compared with DKK 190,306 the year before. Equity in the 2025 report amounted to DKK 2,565,468.
